國立虎尾科技大學 |

Agammaglobulinemia

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Agammaglobulinemia/ edited by Alessandro Plebani, Vassilios Lougaris.
other author:	Lougaris, Vassilios.
Published:	Cham :Imprint: Springer, : 2015.,
Description:	ix, 119 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Cell Biology. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-22714-6
ISBN:	9783319227146

Agammaglobulinemia
Agammaglobulinemia[electronic resource] /edited by Alessandro Plebani, Vassilios Lougaris. - Cham :Imprint: Springer,2015. - ix, 119 p. :ill., digital ;24 cm. - Rare diseases of the immune system,42282-6505 ;. - Rare diseases of the immune system ;4..

Early B Cell Biology -- Agammaglobulinemia: Basic Pathogenesis and Clinical Spectrum (Including X-Linked and Autosomal Recessive Forms) -- Pulmonary Complications in Agammaglobulinemia -- Immunoglobulin Replacement Therapy: Past, Present, Future -- Mutational Spectrum of BTK: A Comprehensive Description -- Novel Therapeutic Options for X-Linked Agammaglobulinemia -- BTK in Non B Cells.

This book provides an updated overview of agammaglobulinemia, a rare form of primary immunodeficiency which is considered the prototype of the congenital humoral defects, and which is characterized by the absence of peripheral B cells and very low serum immunoglobulin levels. The book opens by discussing the highly orchestrated early B cell development in the bone marrow and the genes involved based on both human and animal models. The pathogenesis and clinical presentation of X-linked agammaglobulinemia, caused by mutations in the BTK (Bruton's tyrosine kinase) gene, are then presented in detail, followed by descriptions of the clinical manifestations and molecular basis of the less frequent autosomal recessive and autosomal dominant forms of agammaglobulinemia. Patients' management in terms of respiratory complications, gammaglobulin replacement therapy and the potential value of novel experimental therapeutic strategies are discussed. The book's closing chapters offer a comprehensive and updated description of mutations in the BTK gene, and the expression and function of BTK in cells other than B cells.

ISBN: 9783319227146

Standard No.: 10.1007/978-3-319-22714-6doiSubjects--Topical Terms:

593889
Cell Biology.

LC Class. No.: RC606

Dewey Class. No.: 616.979

Agammaglobulinemia
LDR:02489nam a2200325 a 4500 001 838744
003 DE-He213
005 20160411134223.0
006 m d
007 cr nn 008maaau
008 160616s2015 gw s 0 eng d
020 $a 9783319227146 $q (electronic bk.)
020 $a 9783319227139 $q (paper)
024 7 $a 10.1007/978-3-319-22714-6 $2 doi
035 $a 978-3-319-22714-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC606
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.979 $2 23
090 $a RC606 $b .A259 2015
245 0 0 $a Agammaglobulinemia $h [electronic resource] / $c edited by Alessandro Plebani, Vassilios Lougaris.
260 $a Cham : $c 2015. $b Imprint: Springer, $b Springer International Publishing :
300 $a ix, 119 p. : $b ill., digital ; $c 24 cm.
490 1 $a Rare diseases of the immune system, $x 2282-6505 ; $v 4
505 0 $a Early B Cell Biology -- Agammaglobulinemia: Basic Pathogenesis and Clinical Spectrum (Including X-Linked and Autosomal Recessive Forms) -- Pulmonary Complications in Agammaglobulinemia -- Immunoglobulin Replacement Therapy: Past, Present, Future -- Mutational Spectrum of BTK: A Comprehensive Description -- Novel Therapeutic Options for X-Linked Agammaglobulinemia -- BTK in Non B Cells.
520 $a This book provides an updated overview of agammaglobulinemia, a rare form of primary immunodeficiency which is considered the prototype of the congenital humoral defects, and which is characterized by the absence of peripheral B cells and very low serum immunoglobulin levels. The book opens by discussing the highly orchestrated early B cell development in the bone marrow and the genes involved based on both human and animal models. The pathogenesis and clinical presentation of X-linked agammaglobulinemia, caused by mutations in the BTK (Bruton's tyrosine kinase) gene, are then presented in detail, followed by descriptions of the clinical manifestations and molecular basis of the less frequent autosomal recessive and autosomal dominant forms of agammaglobulinemia. Patients' management in terms of respiratory complications, gammaglobulin replacement therapy and the potential value of novel experimental therapeutic strategies are discussed. The book's closing chapters offer a comprehensive and updated description of mutations in the BTK gene, and the expression and function of BTK in cells other than B cells.
650 2 4 $a Cell Biology. $3 593889
650 2 4 $a Pediatrics. $3 644839
650 2 4 $a Hematology. $3 645254
650 2 4 $a Rheumatology. $3 668542
650 2 4 $a Immunology. $3 592892
650 1 4 $a Biomedicine. $3 593880
650 0 $a Agammaglobulinemia $x Treatment. $3 1070096
650 0 $a Agammaglobulinemia. $3 1070095
700 1 $a Lougaris, Vassilios. $3 1070093
700 1 $a Plebani, Alessandro. $3 1070092
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Rare diseases of the immune system ; $v 4. $3 1070094
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-22714-6
950 $a Medicine (Springer-11650)